6 Hrs
Source:
مباشر
_1777294237270_124456903.png&w=64&q=75){kind=small}
Moderna Raises Revenue
Moderna raised its forecast for annual revenue growth in 2026 to between 15% and 25%, supported by strong international demand for its COVID-19 vaccine and payments from strategic partnerships. In the third quarter, the company posted net income of $162 million, compared with a loss of $200 million a year earlier, and revenue of $1.3 billion, exceeding analysts’ expectations. Its shares jumped more than 10%.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)